Atossa Therapeutics, Inc.
corporate_fare Company Profile
Atossa Therapeutics, Inc. (NASDAQ:ATOS) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 26 items for ATOS at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Atossa Therapeutics Terminates $100 Million At-The-Market (ATM) Offering Program
- Atossa Therapeutics Regains Nasdaq Compliance, Averting Delisting
- Atossa Therapeutics Highlights Positive Clinical Data and Key FDA Designations in Shareholder Letter
- Atossa Therapeutics Approves 15:1 Reverse Stock Split to Maintain Nasdaq Listing
- Atossa Therapeutics Reports Strong Cash Position with $40M and Over One Year of Runway
Financial Snapshot
Fiscal year ended December 31, 2025
Net Income
-$34.77M
Diluted EPS
-$4.04
Op. Cash Flow
-$29.76M
Free Cash Flow
-$29.79M
Operating Income
-$37.14M
Cash & Equivalents
$41.3M
Debt / Equity
0.00×
Shares Outstanding
8.61M sh
Source: 10-K · filed 2026-03-25 · accession 0001193125-26-124396
show_chartPrice Chart
Loading chart...
feed ATOS - Filings & News (Page 2)
ATOS
Feb 20, 2026, 4:07 PM EST
Price at Filing:
$4.21
Real-time Price:
$1.65
Change:
-$2.56 (-61%)
Market Cap:
$15.917M
ATOS
Feb 17, 2026, 4:30 PM EST
Price at Filing:
$4.15
Real-time Price:
$1.65
Change:
-$2.50 (-60%)
Market Cap:
$15.917M
ATOS
Feb 11, 2026, 8:45 AM EST
Atossa Therapeutics Highlights Positive Clinical Data and Key FDA Designations in Shareholder Letter
Price at Filing:
$4.82
Real-time Price:
$1.65
Change:
-$3.17 (-66%)
Market Cap:
$15.917M
ATOS
Jan 26, 2026, 8:00 AM EST
Price at Filing:
$0.659
Real-time Price:
$1.65
Change:
Reverse Stock Split
Market Cap:
$15.917M
ATOS
Jan 09, 2026, 8:15 AM EST
Price at Filing:
$0.6653
Real-time Price:
$1.65
Change:
Reverse Stock Split
Market Cap:
$15.917M
ATOS
Jan 06, 2026, 8:30 AM EST
Price at Filing:
$0.6341
Real-time Price:
$1.65
Change:
Reverse Stock Split
Market Cap:
$15.917M